-
Caspase-3 Colorimetric Assay Kit Guide
2026-08-18
The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a substrate-based method for measuring DEVD-dependent caspase-3 activity in biological lysates by monitoring released p-nitroaniline at 400 or 405 nm. It is suitable for relative apoptosis and caspase activity measurement, but it should not be used alone to establish caspase-3 identity, apoptosis mechanism, or absolute enzyme concentration.
-
Cepharanthine in Endometriosis: Organoid and In Vivo Evidenc
2026-08-17
A 2026 study evaluated Cepharanthine across immortalized stromal cells, patient-derived endometriotic cells, endometrial organoids, and a murine peritoneal model. Its central contribution is the convergence of patient-derived organoid evidence with mechanistic data linking growth suppression to G0/G1 arrest, DNA damage, impaired repair, and mitochondrial apoptosis.
-
Alternariol and LX-2 Fibrotic Transdifferentiation
2026-08-17
The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can push LX-2 hepatic stellate cells toward a contractile, extracellular-matrix-producing myofibroblast phenotype, linking emerging Alternaria toxins to liver fibrosis biology. Its lncRNA-mRNA omics strategy also identifies pathway-level signals involving NF-κB, ferroptosis, and AMPK/AKT/mTOR-related autophagy, while proposing CotA laccase as a route for AOH detoxification.
-
25-Hydroxycholesterol Reprograms TAM Immunity
2026-08-16
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint in tumor-associated macrophages. Their work connects lysosomal lipid sensing to AMPK activation, STAT6 phosphorylation, ARG1 production, and suppression of antitumor T-cell immunity, while showing that CH25H targeting can improve responses to anti-PD-1 therapy.
-
OSMI-1 in O-GlcNAc Transferase Workflows
2026-08-15
OSMI-1 is a cell-permeable O-GlcNAc transferase inhibitor for testing how OGT activity shapes protein modification, stress responses, and ferroptosis-related phenotypes. This workflow-focused guide covers dose selection, pharmacodynamic validation, trophoblast applications, controls, and troubleshooting.
-
RCN2 Drives ESCC Metastasis and Cisplatin Resistance
2026-08-14
This study identifies RCN2 as a mechanistic driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance. It shows that RCN2 recruits the HECT-domain E3 ligase UBR5 to promote PPP2CA ubiquitination and degradation, thereby activating PI3K-AKT signaling and revealing a potential therapeutic vulnerability.
-
MG-132 Workflows for Proteasome and Podocyte Assays
2026-08-14
MG-132 (Z-LLL-al) combines cell permeability with potent proteasome inhibition for apoptosis assay, cell-cycle, redox, and protein-turnover workflows. This guide translates its use into practical cancer and podocyte experiments while emphasizing dose finding, orthogonal readouts, and troubleshooting.
-
mRNA Nanovaccine for RA and Associated Pneumonia
2026-08-13
The reference study presents MPDA@RC@HM, a systemically administered mRNA nanovaccine designed to regulate immunity in both arthritic joints and the lungs. By combining rapamycin-loaded mesoporous polydopamine, type II collagen epitope-encoding mRNA, hyaluronic acid, and dendritic cell membrane modification, the platform aims to address rheumatoid arthritis and associated pulmonary disease in a single treatment strategy.
-
Tobramycin: From MIC Data to Assay Design
2026-08-13
Tobramycin is an aminoglycoside antibiotic whose value in microbiology research depends on more than its 30S-ribosome mechanism. This guide shows how historical susceptibility methods, physicochemical properties, and resistance-aware assay design can be integrated into interpretable experiments.
-
Degarelix Acetate: Evidence in Prostate Cancer
2026-08-12
The 2009 review by Laurence Klotz examines degarelix acetate as a third-generation GnRH antagonist that produces rapid testosterone suppression without the initial hormonal flare associated with GnRH agonists. Its synthesis of phase II and phase III evidence highlights faster castration and PSA responses, while also identifying injection-site reactions and the need for longer-term disease-management strategies.
-
Cepharanthine Inhibits Endometriosis Growth
2026-08-12
A 2026 study tested Cepharanthine across immortalized stromal cells, patient-derived endometriotic cells, endometrial organoids, and a mouse model. The results connect lesion suppression with G0/G1 arrest, DNA damage, impaired repair, and mitochondria-linked apoptosis, while also illustrating how organoids can strengthen preclinical endometriosis research.
-
Direct Mouse Genotyping Kit Plus for Lineage Studies
2026-08-11
The Direct Mouse Genotyping Kit Plus supports rapid, purification-free genotyping for lineage-tracing and immune-microenvironment research. Learn how to connect reliable allele calls with the dynamic macrophage biology revealed by recent liver-metastasis studies.
-
Bazedoxifene Workflows for Osteoporosis Research
2026-08-11
Build more informative estrogen receptor assays with Bazedoxifene by pairing receptor pharmacology, estrogen-challenge controls, and bone-relevant endpoints. This workflow connects cell-based mechanism studies with ovariectomized-animal models while addressing solubility, vehicle, dosing, and interpretation challenges.
-
Cepharanthine in Organoid Apoptosis Research
2026-08-10
Cepharanthine supports a three-tier endometriosis workflow spanning stromal cells, patient-derived organoids, and a peritoneal mouse model. This guide explains formulation, assay design, translational use cases, and troubleshooting while separating published findings from practical starting conditions.
-
Protease Inhibitor Cocktail for Lipid Droplet Assays
2026-08-09
Protect DFCP1–ATGL complexes and other labile proteins during lipid droplet extraction, Western blotting, Co-IP, and fractionation. This water-soluble 100X formulation offers broad inhibitor coverage, while its EDTA component requires deliberate validation for metal-dependent assays and purification.